#lymphoma

Celebrities who share their cancer diagnoses may inspire some people while triggering others.

Fred Hutch study suggests certain immune cells are the source of antibodies that attack donated organs.

Women with lymphoma who received treatment in the afternoon had lower relapse and mortality rates than those treated earlier in the day.

Scientists from the Leukemia & Lymphoma Society participated in a career development program for college members. Here’s what they said.

For Steve Buechler, terms like “journey” and “battle” fail to describe his experiences with leukemia. Other people with cancer agree.

Approved for CLL and SLL—types of leukemia and lymphoma—Brukinsa caused fewer heart-related side effects in trials.

The Dana-Farber led ALPINE trial looked at the drug in relapsed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Immunotherapy leads the way, along with promising breakthroughs for treating leukemia and multiple myeloma.

Many cancer patients eligible for CAR-T therapy must live away from home for several months while they complete treatment.

After treatment for multiple myeloma, Bryon Daily pays it forward to other African Americans, who are at higher risk for this cancer.

People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

The first two people treated with the “living drug” remained cancer-free for a decade and can be considered cured.

Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.

Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects.

Carcinogenic air pollution is often concentrated in communities of color.